MIT’s Sloan School and Computer Science and Artificial Intelligence Lab researchers together with leading pharma data scientists use crowdsourcing to better forecast drug approvals

CAMBRIDGE, Mass. , July 20, In late 2019, researchers at the MIT Laboratory for Financial Engineering (LFE) and the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) worked with Novartis —a leading global medicines company—to launch an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes.

Read the source article at PR Newswire
2021-07-20 19:11:00